Confinement effects on drugs in thermally hydrocarbonized porous silicon

Langmuir

Volumn 30, Issue 8, 2014, Pages 2196-2205

  Mäkilä, Ermei ^a,b   Ferreira, Mónica P A ^b   Kivelä, Henri ^a   Niemi, Sanna Mari ^a   Correia, Alexandra ^b   Shahbazi, Mohammad Ali ^b   Kauppila, Jussi ^a   Hirvonen, Jouni ^b   Santos, Hélder A ^b   Salonen, Jarno ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMORPHOUS CLUSTERS; CONFINEMENT EFFECTS; DENSITY REDUCTION; DISSOLUTION TESTS; EXTERNAL SURFACES; HELIUM PYCNOMETRY; SIMULATED GASTRIC FLUID (SGF); TRANSVERSE RELAXATION TIME;

DISSOLUTION; MOLECULES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RELAXATION TIME; STRESS ANALYSIS;

POROUS SILICON;

GRISEOFULVIN; INDOMETACIN; SILICON;

ARTICLE; CHEMISTRY; DRUG DELIVERY SYSTEM; INFRARED SPECTROSCOPY; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PH; POROSITY; STOMACH JUICE;

DRUG DELIVERY SYSTEMS; GASTRIC JUICE; GRISEOFULVIN; HYDROGEN-ION CONCENTRATION; INDOMETHACIN; MAGNETIC RESONANCE SPECTROSCOPY; POROSITY; SILICON; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84897712491     PISSN: 07437463     EISSN: 15205827     Source Type: Journal    
DOI: 10.1021/la404257m     Document Type: Article

References (58)

1. Stegemann, S.; Leveiller, F.; Franchi, D.; de Jong, H.; Lindén, H. When Poor Solubility Becomes an Issue: From Early Stage to Proof of Concept Eur. J. Pharm. Sci. 2007, 31, 249-61
2. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings Adv. Drug Delivery Rev. 2001, 46, 3-26
3. Leuner, C.; Dressman, J. Improving Drug Solubility for Oral Delivery Using Solid Dispersions Eur. J. Pharm. Biopharm. 2000, 50, 47-60
4. Ku, M. S.; Dulin, W. A Biopharmaceutical Classification-Based Right-First-Time Formulation Approach to Reduce Human Pharmacokinetic Variability and Project Cycle Time from First-In-Human to Clinical Proof-Of-Concept Pharm. Dev. Technol. 2012, 17, 285-302
5. Serajuddin, A. T. M. Salt Formation to Improve Drug Solubility Adv. Drug Delivery Rev. 2007, 59, 603-16
6. Blagden, N.; de Matas, M.; Gavan, P. T.; York, P. Crystal Engineering of Active Pharmaceutical Ingredients to Improve Solubility and Dissolution Rates Adv. Drug Delivery Rev. 2007, 59, 617-30
7. Elder, D. P.; Holm, R.; Diego, H. L. De Use of Pharmaceutical Salts and Cocrystals to Address the Issue of Poor Solubility Int. J. Pharm. 2013, 453, 88-100
8. Rasenack, N.; Müller, B. W. Dissolution Rate Enhancement by in Situ Micronization of Poorly Water-Soluble Drugs Pharm. Res. 2002, 19, 1894-900
9. Hancock, B. C.; Parks, M. What Is the True Solubility Advantage for Amorphous Pharmaceuticals? Pharm. Res. 2000, 17, 397-404
10. Hancock, B. C.; Zografi, G. Characteristics and Significance of the Amorphous State in Pharmaceutical Systems J. Pharm. Sci. 1997, 86, 1-12
11. Yu, L. Amorphous Pharmaceutical Solids: Preparation, Characterization and Stabilization Adv. Drug Delivery Rev. 2001, 48, 27-42
12. Greco, K.; Bogner, R. Crystallization of Amorphous Indomethacin During Dissolution: Effect of Processing and Annealing Mol. Pharmaceutics 2010, 7, 1406-18
13. Ahmed, H.; Buckton, G.; Rawlins, D. A. Crystallisation of Partially Amorphous Griseofulvin in Water Vapour: Determination of Kinetic Parameters Using Isothermal Heat Conduction Microcalorimetry Int. J. Pharm. 1998, 167, 139-145
14. Löbmann, K.; Laitinen, R.; Grohganz, H.; Gordon, K. C.; Strachan, C.; Rades, T. Coamorphous Drug Systems: Enhanced Physical Stability and Dissolution Rate of Indomethacin and Naproxen Mol. Pharmaceutics 2011, 8, 1919-28
15. Laitinen, R.; Löbmann, K.; Strachan, C. J.; Grohganz, H.; Rades, T. Emerging Trends in the Stabilization of Amorphous Drugs Int. J. Pharm. 2013, 453, 65-79
16. Salonen, J.; Kaukonen, A. M.; Hirvonen, J.; Lehto, V. P. Mesoporous Silicon in Drug Delivery Applications J. Pharm. Sci. 2008, 97, 632-653
17. Manzano, M.; Colilla, M.; Vallet-Regí, M. Drug Delivery from Ordered Mesoporous Matrices Expert Opin. Drug Delivery 2009, 6, 1383-400
18. Qian, K. K.; Bogner, R. H. Application of Mesoporous Silicon Dioxide and Silicate in Oral Amorphous Drug Delivery Systems J. Pharm. Sci. 2012, 101, 444-63
19. Anglin, E. J.; Cheng, L.; Freeman, W. R.; Sailor, M. J. Porous Silicon in Drug Delivery Devices and Materials Adv. Drug Delivery Rev. 2008, 60, 1266-77
20. Prestidge, C. A.; Barnes, T. J.; Lau, C.-H.; Barnett, C.; Loni, A.; Canham, L. Mesoporous Silicon: a Platform for the Delivery of Therapeutics Expert Opin. Drug Delivery 2007, 4, 101-10
21. Alba-Simionesco, C.; Coasne, B.; Dosseh, G.; Dudziak, G.; Gubbins, K. E.; Radhakrishnan, R.; Sliwinska-Bartkowiak, M. Effects of Confinement on Freezing and Melting J. Phys.: Condens. Matter 2006, 18, R15-R68
22. Lyklema, J. Adsorption at Solid-liquid Interfaces with Special Reference to Emulsion Systems Colloids Surf., A 1994, 91, 25-38
23. Nieto, A.; Colilla, M.; Balas, F.; Vallet-Regí, M. Surface Electrochemistry of Mesoporous Silicas as a Key Factor in the Design of Tailored Delivery Devices Langmuir 2010, 26, 5038-49
24. Mellaerts, R.; Jammaer, J. A. G.; Van Speybroeck, M.; Chen, H.; Van Humbeeck, J.; Augustijns, P.; Van den Mooter, G.; Martens, J. A. Physical State of Poorly Water Soluble Therapeutic Molecules Loaded into SBA-15 Ordered Mesoporous Silica Carriers: a Case Study with Itraconazole and Ibuprofen Langmuir 2008, 24, 8651-9
25. Vogt, F. G.; Roberts-Skilton, K.; Kennedy-Gabb, S. A. A Solid-State NMR Study of Amorphous Ezetimibe Dispersions in Mesoporous Silica Pharm. Res. 2013, 30, 2315-31
26. Salonen, J.; Laitinen, L.; Kaukonen, A. M.; Tuura, J.; Björkqvist, M.; Heikkilä, T.; Vähä-Heikkilä, K.; Hirvonen, J.; Lehto, V.-P. Mesoporous Silicon Microparticles for Oral Drug Delivery: Loading and Release of Five Model Drugs J. Controlled Release 2005, 108, 362-74
27. Wang, F.; Hui, H.; Barnes, T. J.; Barnett, C.; Prestidge, C. A. Oxidized Mesoporous Silicon Microparticles for Improved Oral Delivery of Poorly Soluble Drugs Mol. Pharmaceutics 2010, 7, 227-36
28. Jarvis, K. L.; Barnes, T. J.; Prestidge, C. A. Thermal Oxidation for Controlling Protein Interactions with Porous Silicon Langmuir 2010, 26, 14316-22
29. Buriak, J. M. Organometallic Chemistry on Silicon and Germanium Surfaces Chem. Rev. 2002, 102, 1271-308
30. Salonen, J.; Björkqvist, M.; Laine, E.; Niinistö, L. Stabilization of Porous Silicon Surface by Thermal Decomposition of Acetylene Appl. Surf. Sci. 2004, 225, 389-394
31. Kovalainen, M.; Mönkäre, J.; Mäkilä, E.; Salonen, J.; Lehto, V.-P.; Herzig, K.-H.; Järvinen, K. Mesoporous Silicon (PSi) for Sustained Peptide Delivery: Effect of PSi Microparticle Surface Chemistry on Peptide YY3-36 Release Pharm. Res. 2012, 29, 837-46
32. Jalkanen, T.; Mäkilä, E.; Suzuki, Y.-I.; Urata, T.; Fukami, K.; Sakka, T.; Salonen, J.; Ogata, Y. H. Studies on Chemical Modification of Porous Silicon-Based Graded-Index Optical Microcavities for Improved Stability Under Alkaline Conditions Adv. Funct. Mater. 2012, 22, 3890-3898
33. Santos, H. A.; Riikonen, J.; Salonen, J.; Mäkilä, E.; Heikkilä, T.; Laaksonen, T.; Peltonen, L.; Lehto, V.-P.; Hirvonen, J. In Vitro Cytotoxicity of Porous Silicon Microparticles: Effect of the Particle Concentration, Surface Chemistry and Size Acta Biomater. 2010, 6, 2721-31
34. Bimbo, L. M.; Denisova, O. V.; Mäkilä, E.; Kaasalainen, M.; De Brabander, J. K.; Hirvonen, J.; Salonen, J.; Kakkola, L.; Kainov, D.; Santos, H. A. Inhibition of Influenza A Virus Infection in Vitro by Saliphenylhalamide- Loaded Porous Silicon Nanoparticles ACS Nano 2013, 7, 6884-93
35. Bimbo, L. M.; Mäkilä, E.; Raula, J.; Laaksonen, T.; Laaksonen, P.; Strommer, K.; Kauppinen, E. I.; Salonen, J.; Linder, M. B.; Hirvonen, J.; Santos, H. A. Functional Hydrophobin-Coating of Thermally Hydrocarbonized Porous Silicon Microparticles Biomaterials 2011, 32, 9089-9099
36. Rosenholm, J. M.; Lindén, M. Wet-Chemical Analysis of Surface Concentration of Accessible Groups on Different Amino-Functionalized Mesoporous SBA-15 Silicas Chem. Mater. 2007, 19, 5023-5034
37. Brunauer, S.; Emmett, P.; Teller, E. Adsorption of Gases in Multimolecular Layers J. Am. Chem. Soc. 1938, 60, 309-319
38. Sing, K.; Everett, D.; Haul, R.; Moscou, L.; Pierotti, R.; Rouquerol, J.; Siemieniewska, T. Reporting Physisorption Data for Gas/Solid Systems Pure Appl. Chem. 1985, 57, 603-619
39. Barrett, E. P.; Joyner, L. G.; Halenda, P. P. The Determination of Pore Volume and Area Distributions in Porous Substances. I. Computations from Nitrogen Isotherms J. Am. Chem. Soc. 1951, 73, 373-380
40. Galia, E.; Nicolaides, E.; Hörter, D.; Löbenberg, R.; Reppas, C.; Dressman, J. B. Evaluation of Various Dissolution Media for Predicting in Vivo Performance of Class I and II Drugs Pharm. Res. 1998, 15, 698-705
41. Föll, H.; Christophersen, M.; Carstensen, J.; Hasse, G. Formation and Application of Porous Silicon Mater. Sci. Eng., R 2002, 39, 93-141
42. Christenson, H. Confinement Effects on Freezing and Melting J. Phys.: Condens. Matter 2001, 13, R95-R133
43. Riikonen, J.; Mäkilä, E.; Salonen, J.; Lehto, V.-P. Determination of the Physical State of Drug Molecules in Mesoporous Silicon with Different Surface Chemistries Langmuir 2009, 25, 6137-42
44. Carpentier, L.; Decressain, R.; Desprez, S.; Descamps, M. Dynamics of the Amorphous and Crystalline a-, g-Phases of Indomethacin J. Phys. Chem. B 2006, 110, 457-464
45. Zhou, D.; Zhang, G. G. Z.; Law, D.; Grant, D. J. W.; Schmitt, E. A. Thermodynamics, Molecular Mobility and Crystallization Kinetics of Amorphous Griseofulvin Mol. Pharmaceutics 2008, 5, 927-36
46. Mahieu, A.; Willart, J.; Dudognon, E.; Eddleston, M. D.; Jones, W.; Danède, F.; Descamps, M. On the Polymorphism of Griseofulvin: Identification of Two Additional Polymorphs J. Pharm. Sci. 2013, 102, 462-8
47. Yoshioka, M.; Hancock, B. C.; Zografi, G. Crystallization of Indomethacin from the Amorphous State Below and Above Its Glass Transition Temperature J. Pharm. Sci. 1994, 83, 1700-1705
48. Zhu, L.; Jona, J.; Nagapudi, K.; Wu, T. Fast Surface Crystallization of Amorphous Griseofulvin Below T G Pharm. Res. 2010, 27, 1558-67
49. Mellaerts, R.; Fayad, E. J.; Van den Mooter, G.; Augustijns, P.; Rivallan, M.; Thibault-Starzyk, F.; Martens, J. A. In Situ FT-IR Investigation of Etravirine Speciation in Pores of SBA-15 Ordered Mesoporous Silica Material Upon Contact with Water Mol. Pharmaceutics 2013, 10, 567-73
50. Ukmar, T.; Čendak, T.; Mazaj, M.; Kaučič, V.; Mali, G. Structural and Dynamical Properties of Indomethacin Molecules Embedded Within the Mesopores of SBA-15: A Solid-State NMR View J. Phys. Chem. C 2012, 116, 2662-2671
51. Van Speybroeck, M.; Barillaro, V.; Thi, T.; Do Mellaerts, R.; Martens, J.; Van Humbeeck, J.; Vermant, J.; Annaert, P.; Van den Mooter, G.; Augustijns, P. Ordered Mesoporous Silica Material SBA-15: a Broad-Spectrum Formulation Platform for Poorly Soluble Drugs J. Pharm. Sci. 2009, 98, 2648-58
52. Ukmar, T.; Godec, A.; Planinšek, O.; Kaučič, V.; Mali, G.; Gaberšček, M. The Phase (trans)formation and Physical State of a Model Drug in Mesoscopic Confinement Phys. Chem. Chem. Phys. 2011, 13, 16046-54
53. Löbmann, K.; Laitinen, R.; Grohganz, H.; Strachan, C.; Rades, T.; Gordon, K. C. A Theoretical and Spectroscopic Study of Co-Amorphous Naproxen and Indomethacin Int. J. Pharm. 2012, 2, 1-8
54. Al-Obaidi, H.; Buckton, G. Evaluation of Griseofulvin Binary and Ternary Solid Dispersions with HPMCAS AAPS PharmSciTech 2009, 10, 1172-7
55. Azaïs, T.; Tourné-Péteilh, C.; Aussenac, F.; Baccile, N.; Coelho, C.; Devoisselle, J.-M.; Babonneau, F. Solid-State NMR Study of Ibuprofen Confined in MCM-41 Material Chem. Mater. 2006, 18, 6382-6390
56. Azais, T.; Hartmeyer, G.; Quignard, S.; Laurent, G.; Babonneau, F. Solution State NMR Techniques Applied to Solid State Samples: Characterization of Benzoic Acid Confined in MCM-41 J. Phys. Chem. C 2010, 114, 8884-8891
57. Mellaerts, R.; Roeffaers, M. B. J.; Houthoofd, K.; Van Speybroeck, M.; De Cremer, G.; Jammaer, J. A. G.; Van den Mooter, G.; Augustijns, P.; Hofkens, J.; Martens, J. A. Molecular Organization of Hydrophobic Molecules and Co-Adsorbed Water in SBA-15 Ordered Mesoporous Silica Material Phys. Chem. Chem. Phys. 2011, 13, 2706-13
58. Kaukonen, A. M.; Laitinen, L.; Salonen, J.; Tuura, J.; Heikkilä, T.; Limnell, T.; Hirvonen, J.; Lehto, V.-P. Enhanced in Vitro Permeation of Furosemide Loaded into Thermally Carbonized Mesoporous Silicon (TCPSi) Microparticles Eur. J. Pharm. Biopharm. 2007, 66, 348-56